Johanna Winter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Johanna Winter has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Stefan Bartzsch
Department of Radiation Oncology, TUM School of Medicine and Health, TUM University Hospital, Technical University of Munich, Ismaninger Straße 22, 81675 Munich, Germany
7 shared publications - Stephanie Elisabeth Combs
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Str. 22, 81675 Munich, Germany
5 shared publications - Jan Jakob Wilkens
Technical University of Munich (TUM)
4 shared publications - Mabroor Ahmed
Department of Radiation Oncology, TUM School of Medicine and Health, TUM University Hospital, Technical University of Munich, Ismaninger Straße 22, 81675 Munich, Germany
4 shared publications Anton Dimroth
Forschungs-Neutronenquelle Heinz Maier-Leibnitz Zentrum (FRM II), Technical University of Munich (TUM), Garching, Germany; Central Institute for Engineering, Electronics and Analytics (ZEA-1), Forschungszentrum Jülich GmbH, Jülich, Germany
3 shared publicationsKurt Aulenbacher
Johannes Gutenberg-Universität Mainz, Institut für Kernphysik, Mainz, Germany; GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany; Helmholtz-Institut Mainz, Germany
3 shared publications
Latest Publications
- Open Access
- 10 March 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (3) , 678
The Combination of Temporal and Spatial Dose Fractionation in Microbeam Radiation Therapy
Background: Microbeam radiation therapy (MRT) is an advanced preclinical approach in radiotherapy that utilizes spatially fractionated dose distributions by collimating x-rays into micrometer-wide, planar beams. While the benefits of temporal fractionation are well established and widely incorporated into conventional radiotherapy protocols, the interplay between MRT and temporal dose fractionation remains largely unexplored. In this study, we investigate the effects of combining temporal and spatial dose fractionation by assessing clonogenic cell survival following temporally fractionated MRT with varying irradiation angles, compared to conventional broad-beam (BB) irradiation. Methods: A lung tumor cell line (A549) and a normal lung cell line (MRC-5) were irradiated with a total number of four fractions with a 24 h interval between each fraction. We compared a temporally fractionated BB regime to two temporally fractionated MRT schemes with either overlapping MRT fields or MRT fields with a 45° rotation per fraction. Subsequently, the clonogenic cell survival assay was used by analyzing the corresponding survival fractions (SFs). Results: The clonogenic survival of A549 tumor cells differed significantly between microbeam radiation therapy with rotation (MRT + R) and overlapping MRT. However, neither MRT + R nor overlapping MRT showed statistically significant differences compared to the broad-beam (BB) irradiation for A549. In contrast, the normal tissue cell line MRC-5 exhibited significantly higher clonogenic survival following both MRT + R and overlapping MRT compared to BB. Conclusions: This study demonstrates that combining temporal and spatial fractionation enhances normal tissue cell survival while maintaining equivalent tumor cell kill, potentially increasing the therapeutic index. Our findings support the feasibility of delivering temporally fractionated doses using different MRT modalities and provide clear evidence of the therapeutic benefits of temporally fractionated MRT.
- 10 March 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (3) , 678
Open AccessThe Combination of Temporal and Spatial Dose Fractionation in Microbeam Radiation Therapy
Background: Microbeam radiation therapy (MRT) is an advanced preclinical approach in radiotherapy that utilizes spatially fractionated dose distributions by collimating x-rays into micrometer-wide, planar beams. While the benefits of temporal fractionation are well established and widely incorporated into conventional radiotherapy protocols, the interplay between MRT and temporal dose fractionation remains largely unexplored. In this study, we investigate the effects of combining temporal and spatial dose fractionation by assessing clonogenic cell survival following temporally fractionated MRT with varying irradiation angles, compared to conventional broad-beam (BB) irradiation. Methods: A lung tumor cell line (A549) and a normal lung cell line (MRC-5) were irradiated with a total number of four fractions with a 24 h interval between each fraction. We compared a temporally fractionated BB regime to two temporally fractionated MRT schemes with either overlapping MRT fields or MRT fields with a 45° rotation per fraction. Subsequently, the clonogenic cell survival assay was used by analyzing the corresponding survival fractions (SFs). Results: The clonogenic survival of A549 tumor cells differed significantly between microbeam radiation therapy with rotation (MRT + R) and overlapping MRT. However, neither MRT + R nor overlapping MRT showed statistically significant differences compared to the broad-beam (BB) irradiation for A549. In contrast, the normal tissue cell line MRC-5 exhibited significantly higher clonogenic survival following both MRT + R and overlapping MRT compared to BB. Conclusions: This study demonstrates that combining temporal and spatial fractionation enhances normal tissue cell survival while maintaining equivalent tumor cell kill, potentially increasing the therapeutic index. Our findings support the feasibility of delivering temporally fractionated doses using different MRT modalities and provide clear evidence of the therapeutic benefits of temporally fractionated MRT.
- Open Access
- 29 January 2025
- Published by ASME International in Journal of Thermal Science and Engineering Applications
- Vol. 17 (3) , 1-26
Design and Validation Strategy for an X-Ray Target Subject to Ultra High Heat Flux Loading
Microbeam X-ray therapy is a promising cancer therapy that uses a high-power electron beam hitting a metallic target. For a clinical microbeam therapy X-ray source, an electron beam of a power of 1 MW onto a focal spot of 0.05 × 20 mm size is needed, with a penetration depth of 0.1 mm. This means a heat flux input of 1 TW/m2, an order of magnitude higher than nuclear and medical applications. Numerical simulations based on surface and volumetric heat loading for such an electron beam are presented in this work. The local temperature around the focal spot is modeled in a lower-scale model with an element size of 10 μm and volumetric heat loading. This differs from the state-of-the-art simulations, in which electron beam loading is modeled as surface heat flux loads. The simulated temperature agrees with the mathematical estimates within an error of 10% while proving feasibility. A novel validation strategy is proposed to address the lack of available test facilities to replicate this extreme heat flux. The critical parameters describing the high heat flux loading are identified as temperature, thermal strain, thermal stress, and strain rate. Scaled-down test specifications are determined to use a test facility of power less than 100 kW. With the verified simulation using the scaled-down test, it is proposed to establish the material's capability to withstand the concentrated 1 MW heat load without a 1 MW test facility.
- 29 January 2025
- Published by ASME International in Journal of Thermal Science and Engineering Applications
- Vol. 17 (3) , 1-26
Open AccessDesign and Validation Strategy for an X-Ray Target Subject to Ultra High Heat Flux Loading
Microbeam X-ray therapy is a promising cancer therapy that uses a high-power electron beam hitting a metallic target. For a clinical microbeam therapy X-ray source, an electron beam of a power of 1 MW onto a focal spot of 0.05 × 20 mm size is needed, with a penetration depth of 0.1 mm. This means a heat flux input of 1 TW/m2, an order of magnitude higher than nuclear and medical applications. Numerical simulations based on surface and volumetric heat loading for such an electron beam are presented in this work. The local temperature around the focal spot is modeled in a lower-scale model with an element size of 10 μm and volumetric heat loading. This differs from the state-of-the-art simulations, in which electron beam loading is modeled as surface heat flux loads. The simulated temperature agrees with the mathematical estimates within an error of 10% while proving feasibility. A novel validation strategy is proposed to address the lack of available test facilities to replicate this extreme heat flux. The critical parameters describing the high heat flux loading are identified as temperature, thermal strain, thermal stress, and strain rate. Scaled-down test specifications are determined to use a test facility of power less than 100 kW. With the verified simulation using the scaled-down test, it is proposed to establish the material's capability to withstand the concentrated 1 MW heat load without a 1 MW test facility.
- Open Access
Superior Anti-Tumor Response After Microbeam and Minibeam Radiation Therapy in a Lung Cancer Mouse Model
Objectives: The present study aimed to compare the tumor growth delay between conventional radiotherapy (CRT) and the spatially fractionated modalities of microbeam radiation therapy (MRT) and minibeam radiation therapy (MBRT). In addition, we also determined the influence of beam width and the peak-to-valley dose ratio (PVDR) on tumor regrowth. Methods: A549, a human non-small-cell lung cancer cell line, was implanted subcutaneously into the hind leg of female CD1-Foxn1nu mice. The animals were irradiated with sham, CRT, MRT, or MBRT. The spatially fractionated fields were created using two specially designed multislit collimators with a beam width of 50 μm and a center-to-center distance (CTC) of 400 μm for MRT and a beam width of 500 μm and 2000 μm CTC for MBRT. Additionally, the concept of the equivalent uniform dose (EUD) was chosen in our study. A dose of 20 Gy was applied to all groups with a PVDR of 20 for MBRT and MRT. Tumor growth was recorded until the tumors reached at least a volume that was at least three-fold of their initial value, and the growth delay was calculated. Results: We saw a significant reduction in tumor regrowth following all radiation modalities. A growth delay of 11.1 ± 8 days was observed for CRT compared to the sham, whereas MBRT showed a delay of 20.2 ± 7.3 days. The most pronounced delay was observed in mice irradiated with MRT PVDR 20, with 34.9 ± 26.3 days of delay. Conclusions: The current study highlights the fact that MRT and MBRT modalities show a significant tumor growth delay in comparison to CRT at equivalent uniform doses.
Open AccessSuperior Anti-Tumor Response After Microbeam and Minibeam Radiation Therapy in a Lung Cancer Mouse Model
Objectives: The present study aimed to compare the tumor growth delay between conventional radiotherapy (CRT) and the spatially fractionated modalities of microbeam radiation therapy (MRT) and minibeam radiation therapy (MBRT). In addition, we also determined the influence of beam width and the peak-to-valley dose ratio (PVDR) on tumor regrowth. Methods: A549, a human non-small-cell lung cancer cell line, was implanted subcutaneously into the hind leg of female CD1-Foxn1nu mice. The animals were irradiated with sham, CRT, MRT, or MBRT. The spatially fractionated fields were created using two specially designed multislit collimators with a beam width of 50 μm and a center-to-center distance (CTC) of 400 μm for MRT and a beam width of 500 μm and 2000 μm CTC for MBRT. Additionally, the concept of the equivalent uniform dose (EUD) was chosen in our study. A dose of 20 Gy was applied to all groups with a PVDR of 20 for MBRT and MRT. Tumor growth was recorded until the tumors reached at least a volume that was at least three-fold of their initial value, and the growth delay was calculated. Results: We saw a significant reduction in tumor regrowth following all radiation modalities. A growth delay of 11.1 ± 8 days was observed for CRT compared to the sham, whereas MBRT showed a delay of 20.2 ± 7.3 days. The most pronounced delay was observed in mice irradiated with MRT PVDR 20, with 34.9 ± 26.3 days of delay. Conclusions: The current study highlights the fact that MRT and MBRT modalities show a significant tumor growth delay in comparison to CRT at equivalent uniform doses.
- Open Access
- 26 December 2024
- Published by Elsevier in Physica Medica
- Vol. 129, 104861
The compact line-focus X-ray tube for microbeam radiation therapy — Focal spot characterisation and collimator design
- 26 December 2024
- Published by Elsevier in Physica Medica
- Vol. 129, 104861
Open AccessThe compact line-focus X-ray tube for microbeam radiation therapy — Focal spot characterisation and collimator design
- Open Access
In Vivo Microbeam Radiation Therapy at a Conventional Small Animal Irradiator
Microbeam radiation therapy (MRT) is a still pre-clinical form of spatially fractionated radiotherapy, which uses an array of micrometer-wide, planar beams of X-ray radiation. The dose modulation in MRT has proven effective in the treatment of tumors while being well tolerated by normal tissue. Research on understanding the underlying biological mechanisms mostly requires large third-generation synchrotrons. In this study, we aimed to develop a preclinical treatment environment that would allow MRT independent of synchrotrons. We built a compact microbeam setup for pre-clinical experiments within a small animal irradiator and present in vivo MRT application, including treatment planning, dosimetry, and animal positioning. The brain of an immobilized mouse was treated with MRT, excised, and immunohistochemically stained against H2AX for DNA double-strand breaks. We developed a comprehensive treatment planning system by adjusting an existing dose calculation algorithm to our setup and attaching it to the open-source software 3D-Slicer. Predicted doses in treatment planning agreed within 10% with film dosimetry readings. We demonstrated the feasibility of MRT exposures in vivo at a compact source and showed that the microbeam pattern is observable in histological sections of a mouse brain. The platform developed in this study will be used for pre-clinical research of MRT.Open AccessIn Vivo Microbeam Radiation Therapy at a Conventional Small Animal Irradiator
Microbeam radiation therapy (MRT) is a still pre-clinical form of spatially fractionated radiotherapy, which uses an array of micrometer-wide, planar beams of X-ray radiation. The dose modulation in MRT has proven effective in the treatment of tumors while being well tolerated by normal tissue. Research on understanding the underlying biological mechanisms mostly requires large third-generation synchrotrons. In this study, we aimed to develop a preclinical treatment environment that would allow MRT independent of synchrotrons. We built a compact microbeam setup for pre-clinical experiments within a small animal irradiator and present in vivo MRT application, including treatment planning, dosimetry, and animal positioning. The brain of an immobilized mouse was treated with MRT, excised, and immunohistochemically stained against H2AX for DNA double-strand breaks. We developed a comprehensive treatment planning system by adjusting an existing dose calculation algorithm to our setup and attaching it to the open-source software 3D-Slicer. Predicted doses in treatment planning agreed within 10% with film dosimetry readings. We demonstrated the feasibility of MRT exposures in vivo at a compact source and showed that the microbeam pattern is observable in histological sections of a mouse brain. The platform developed in this study will be used for pre-clinical research of MRT. - 16 January 2023
- Published by Elsevier in Physica Medica
- Vol. 106, 102532
A novel electron source for a compact x-ray tube for microbeam radiotherapy with very high dose rates
- 16 January 2023
- Published by Elsevier in Physica Medica
- Vol. 106, 102532
A novel electron source for a compact x-ray tube for microbeam radiotherapy with very high dose rates
- Open Access
- 7 April 2022
- Published by Wiley in Medical Physics
- Vol. 49 (5) , 3375-3388
Heat management of a compact x‐ray source for microbeam radiotherapy and FLASH treatments
Background: Microbeam and x‐ray FLASH radiation therapy are innovative concepts that promise reduced normal tissue toxicity in radiation oncology without compromising tumor control. However, currently only large third‐generation synchrotrons deliver acceptable x‐ray beam qualities and there is a need for compact, hospital‐based radiation sources to facilitate clinical translation of these novel treatment strategies.Purpose: We are currently setting up the first prototype of a line‐focus x‐ray tube (LFxT), a promising technology that may deliver ultra‐high dose rates (UHDRs) of more than 100 Gy/s from a table‐top source. The operation of the source in the heat capacity limit allows very high dose rates with micrometer‐sized focal spot widths. Here, we investigate concepts of effective heat management for the LFxT, a prerequisite for the performance of the source.Methods: For different focal spot widths, we investigated the temperature increase numerically with Monte Carlo simulations and finite element analysis (FEA). We benchmarked the temperature and thermal stresses at the focal spot against a commercial x‐ray tube with similar power characteristics. We assessed thermal loads at the vacuum chamber housing caused by scattering electrons in Monte Carlo simulations and FEA. Further, we discuss active cooling strategies and present a design of the rotating target.Results: Conventional focal spot widths led to a temperature increase dominated by heat conduction, while very narrow focal spots led to a temperature increase dominated by the heat capacity of the target material. Due to operation in the heat capacity limit, the temperature increase at the focal spot was lower than for the investigated commercial x‐ray tube. Hence, the thermal stress at the focal spot of the LFxT was considered uncritical. The target shaft and the vacuum chamber housing require active cooling to withstand the high heat loads.Conclusions: The heat capacity limit allows very high power densities at the focal spot of the LFxT and thus facilitates very high dose rates. Numerical simulations demonstrated that the heat load imparted by scattering electrons requires active cooling.
- 7 April 2022
- Published by Wiley in Medical Physics
- Vol. 49 (5) , 3375-3388
Open AccessHeat management of a compact x‐ray source for microbeam radiotherapy and FLASH treatments
Background: Microbeam and x‐ray FLASH radiation therapy are innovative concepts that promise reduced normal tissue toxicity in radiation oncology without compromising tumor control. However, currently only large third‐generation synchrotrons deliver acceptable x‐ray beam qualities and there is a need for compact, hospital‐based radiation sources to facilitate clinical translation of these novel treatment strategies.Purpose: We are currently setting up the first prototype of a line‐focus x‐ray tube (LFxT), a promising technology that may deliver ultra‐high dose rates (UHDRs) of more than 100 Gy/s from a table‐top source. The operation of the source in the heat capacity limit allows very high dose rates with micrometer‐sized focal spot widths. Here, we investigate concepts of effective heat management for the LFxT, a prerequisite for the performance of the source.Methods: For different focal spot widths, we investigated the temperature increase numerically with Monte Carlo simulations and finite element analysis (FEA). We benchmarked the temperature and thermal stresses at the focal spot against a commercial x‐ray tube with similar power characteristics. We assessed thermal loads at the vacuum chamber housing caused by scattering electrons in Monte Carlo simulations and FEA. Further, we discuss active cooling strategies and present a design of the rotating target.Results: Conventional focal spot widths led to a temperature increase dominated by heat conduction, while very narrow focal spots led to a temperature increase dominated by the heat capacity of the target material. Due to operation in the heat capacity limit, the temperature increase at the focal spot was lower than for the investigated commercial x‐ray tube. Hence, the thermal stress at the focal spot of the LFxT was considered uncritical. The target shaft and the vacuum chamber housing require active cooling to withstand the high heat loads.Conclusions: The heat capacity limit allows very high power densities at the focal spot of the LFxT and thus facilitates very high dose rates. Numerical simulations demonstrated that the heat load imparted by scattering electrons requires active cooling.
- Open Access
Treatment Planning Study for Microbeam Radiotherapy Using Clinical Patient Data
Microbeam radiotherapy (MRT) is a novel, still preclinical dose delivery technique. MRT has shown reduced normal tissue effects at equal tumor control rates compared to conventional radiotherapy. Treatment planning studies are required to permit clinical application. The aim of this study was to establish a dose comparison between MRT and conventional radiotherapy and to identify suitable clinical scenarios for future applications of MRT. We simulated MRT treatment scenarios for clinical patient data using an inhouse developed planning algorithm based on a hybrid Monte Carlo dose calculation and implemented the concept of equivalent uniform dose (EUD) for MRT dose evaluation. The investigated clinical scenarios comprised fractionated radiotherapy of a glioblastoma resection cavity, a lung stereotactic body radiotherapy (SBRT), palliative bone metastasis irradiation, brain metastasis radiosurgery and hypofractionated breast cancer radiotherapy. Clinically acceptable treatment plans were achieved for most analyzed parameters. Lung SBRT seemed the most challenging treatment scenario. Major limitations comprised treatment plan optimization and dose calculation considering the tissue microstructure. This study presents an important step of the development towards clinical MRT. For clinical treatment scenarios using a sophisticated dose comparison concept based on EUD and EQD2, we demonstrated the capability of MRT to achieve clinically acceptable dose distributions.
Open AccessTreatment Planning Study for Microbeam Radiotherapy Using Clinical Patient Data
Microbeam radiotherapy (MRT) is a novel, still preclinical dose delivery technique. MRT has shown reduced normal tissue effects at equal tumor control rates compared to conventional radiotherapy. Treatment planning studies are required to permit clinical application. The aim of this study was to establish a dose comparison between MRT and conventional radiotherapy and to identify suitable clinical scenarios for future applications of MRT. We simulated MRT treatment scenarios for clinical patient data using an inhouse developed planning algorithm based on a hybrid Monte Carlo dose calculation and implemented the concept of equivalent uniform dose (EUD) for MRT dose evaluation. The investigated clinical scenarios comprised fractionated radiotherapy of a glioblastoma resection cavity, a lung stereotactic body radiotherapy (SBRT), palliative bone metastasis irradiation, brain metastasis radiosurgery and hypofractionated breast cancer radiotherapy. Clinically acceptable treatment plans were achieved for most analyzed parameters. Lung SBRT seemed the most challenging treatment scenario. Major limitations comprised treatment plan optimization and dose calculation considering the tissue microstructure. This study presents an important step of the development towards clinical MRT. For clinical treatment scenarios using a sophisticated dose comparison concept based on EUD and EQD2, we demonstrated the capability of MRT to achieve clinically acceptable dose distributions.
- Open Access
- 1 April 2020
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 14, 74-81
Clinical microbeam radiation therapy with a compact source: specifications of the line-focus X-ray tube
- 1 April 2020
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 14, 74-81
Open AccessClinical microbeam radiation therapy with a compact source: specifications of the line-focus X-ray tube
- Open Access
- 1 April 2020
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 14, 32-38
Analytical modeling of depth-dose degradation in heterogeneous lung tissue for intensity-modulated proton therapy planning
- 1 April 2020
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 14, 32-38
Open AccessAnalytical modeling of depth-dose degradation in heterogeneous lung tissue for intensity-modulated proton therapy planning